All News about Legend Biotech Corp ADR![]()
Week In Review: AffaMed Announced US Approval To Start Clinical Trials
February 19, 2022
Via Talk Markets
![]() From Legend Biotech
Via Business Wire
![]() ![]()
Legend Biotech Announces FDA Clinical Hold of its Phase 1 Clinical Trial for LB1901
February 15, 2022
From Legend Biotech
Via Business Wire
![]()
Legend Biotech Achieves Milestone Payments in BCMA CAR-T Collaboration with Janssen
February 11, 2022
From Legend Biotech
Via Business Wire
![]() ![]() ![]() ![]() ![]()
Legend Biotech Corporation Announces Pricing of Public Offering
December 16, 2021
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Legend Biotech Corporation Announces Proposed Public Offering
December 14, 2021
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() From Legend Biotech
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|